[PDF][PDF] Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian …
Clin Exp Rheumatol, 2016 - clinexprheumatol.org
Objective. To report the efficacy and tolerability of mycophenolate mofetil (MMF) and
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian …
C Owen, GS Ngian, K Elford, O Moore… - Clinical and …, 2016 - europepmc.org
Objectives To report the efficacy and tolerability of mycophenolate mofetil (MMF) and
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: Results from the Australian …
C Owen, G Ngian, K Elford, O Moore… - Clinical and …, 2016 - research.monash.edu
Objective. To report the efficacy and tolerability of mycophenolate mofetil (MMF) and
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian …
C Owen, G Ngian, K Elford, O Moore, W Stevens… - 2016 - hekyll.services.adelaide.edu.au
OBJECTIVES: To report the efficacy and tolerability of mycophenolate mofetil (MMF) and
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian …
C Owen, GS Ngian, K Elford, O Moore, W Stevens… - clinexprheumatol.org
OBJECTIVES: To report the efficacy and tolerability of mycophenolate mofetil (MMF) and
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian …
C Owen, GS Ngian, K Elford… - Clinical and …, 2016 - pubmed.ncbi.nlm.nih.gov
Objectives To report the efficacy and tolerability of mycophenolate mofetil (MMF) and
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian …
C Owen, GS Ngian, K Elford, O Moore, W Stevens… - 2016 - figshare.utas.edu.au
OBJECTIVES: To report the efficacy and tolerability of mycophenolate mofetil (MMF) and
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian …
C Owen, GS Ngian, K Elford, O Moore, W Stevens… - 2016 - figshare.utas.edu.au
OBJECTIVES: To report the efficacy and tolerability of mycophenolate mofetil (MMF) and
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …
azathioprine (AZA) in the management of systemic sclerosis-associated interstitial lung …